The Novel Serine/Threonine Protein Kinase LmjF.22.0810 from <i>Leishmania major</i> may be Involved in the Resistance to Drugs such as Paromomycin
The identification and clarification of the mechanisms of action of drugs used against leishmaniasis may improve their administration regimens and prevent the development of resistant strains. Herein, for the first time, we describe the structure of the putatively essential Ser/Thr kinase LmjF.22.08...
Main Authors: | Andrés Vacas, Celia Fernández-Rubio, Miriam Algarabel, José Peña-Guerrero, Esther Larrea, Fabio Rocha Formiga, Alfonso T. García-Sosa, Paul A. Nguewa |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-11-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/9/11/723 |
Similar Items
-
LmjF.22.0810 from <i>Leishmania major</i> Modulates the Th2-Type Immune Response and Is Involved in Leishmaniasis Outcome
by: Andrés Vacas, et al.
Published: (2020-10-01) -
The selective estrogen receptor downregulator GDC-0810 is efficacious in diverse models of ER+ breast cancer
by: James D Joseph, et al.
Published: (2016-07-01) -
Identification of the Leishmania major Proteins LmjF07.0430, LmjF07.0440, and LmjF27.2440 as Components of Fatty Acid Synthase II
by: Aner Gurvitz
Published: (2009-01-01) -
Effectiveness of Paromomycin on Cutaneous Leishmaniasis in Iran: A Systematic Review and Meta-Analysis
by: Rahmatollah Moradzadeh, et al.
Published: (2019-05-01) -
Leishmanicidal Activity of Films Containing Paromomycin and Gentamicin Sulfate both In Vitro and In Vivo
by: SH Hejazi, et al.
Published: (2011-09-01)